Literature DB >> 12818618

A brief history of the prevention of infectious diseases by immunisations.

Hervé Bazin1.   

Abstract

Infectious diseases have always been a terrible scourge for humans. The appearance of these plagues, as they were called without distinction, was generally connected to various conditions: asters, climatic changes or religious reasons. The concept of contagious, and then infectious, diseases came slowly. Variolation, i.e. transmission of 'virulent' matter to induce a natural disease and the immunity against it, was brought from Constantinople to England by Lady Montague, in 1721. This 'variolation' technique was also often performed in veterinary medicine against diseases like sheep-pox or pleuropneumonia. As 'vaccination' is the term generally accepted for 'immunisation', variolation can be the word designating such a technique. The second period of the history of immunisation began, in 1880, with the studies of Pasteur and his collaborators. A great number of bacterial vaccines were developed: dead, live but attenuated or only parts of pathogens. The viruses were produced in animals, then in eggs and at last, in tissue cultures. Second generation vaccines appeared with genetic engineering: recombinant vaccines, vector vaccines, nucleic acids vaccines, and markers vaccines, among others. These novel technologies can permit the development of new ones and improve the quality of the vaccines already existing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818618     DOI: 10.1016/S0147-9571(03)00016-X

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  10 in total

Review 1.  Active and passive immunization for cancer.

Authors:  David Baxter
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  The double-edged sword: How evolution can make or break a live-attenuated virus vaccine.

Authors:  Kathryn A Hanley
Journal:  Evolution (N Y)       Date:  2011-12

3.  The Novel Coronavirus (COVID-19): Making a Connection between Infectious Disease Outbreaks and Rehabilitation.

Authors:  Michel D Landry; Anna Tupetz; Djenana Jalovcic; Phillip Sheppard; Tiago S Jesus; Sudha R Raman
Journal:  Physiother Can       Date:  2020-11-01       Impact factor: 1.037

4.  Le nouveau coronavirus (COVID-19) : un lien entre les éclosions de maladies infectieuses et la réadaptation.

Authors:  Michel D Landry; Anna Tupetz; Djenana Jalovcic; Phillip Sheppard; Tiago S Jesus; Sudha R Raman
Journal:  Physiother Can       Date:  2020-11-01       Impact factor: 1.037

5.  Experimental evolution alters the rate and temporal pattern of population growth in Batrachochytrium dendrobatidis, a lethal fungal pathogen of amphibians.

Authors:  Jamie Voyles; Leah R Johnson; Cheryl J Briggs; Scott D Cashins; Ross A Alford; Lee Berger; Lee F Skerratt; Rick Speare; Erica Bree Rosenblum
Journal:  Ecol Evol       Date:  2014-09-03       Impact factor: 2.912

Review 6.  PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.

Authors:  A L Silva; P C Soema; B Slütter; F Ossendorp; W Jiskoot
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

Review 7.  Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern.

Authors:  Khursheed Ul Islam; Thoraya Mohamed Elhassan A-Elgadir; Sarah Afaq; Tanveer Ahmad; Jawed Iqbal
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

Review 8.  The dichotomy of pathogens and allergens in vaccination approaches.

Authors:  Fiona J Baird; Andreas L Lopata
Journal:  Front Microbiol       Date:  2014-07-16       Impact factor: 5.640

Review 9.  Attenuation of Viruses by Large-Scale Recoding of their Genomes: the Selection Is Always Biased.

Authors:  Nikolaus Osterrieder; Dusan Kunec
Journal:  Curr Clin Microbiol Rep       Date:  2018-01-19

10.  COVID-19 Vaccination: Concerns About Its Accessibility, Affordability, and Acceptability.

Authors:  Inayat Ali; Shahbaz Ali; Sehar Iqbal
Journal:  Front Med (Lausanne)       Date:  2021-07-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.